{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:41Z","timestamp":1786119701653,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/wnf.0b013e3182055c07","type":"journal-article","created":{"date-parts":[[2011,1,15]],"date-time":"2011-01-15T01:17:40Z","timestamp":1295054260000},"page":"39-47","source":"Crossref","is-referenced-by-count":50,"title":["Safety and Tolerability of Lamotrigine"],"prefix":"10.1097","volume":"34","author":[{"given":"Ho-Jun","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin A.","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash S.","family":"Masand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Un","family":"Pae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"4","key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4088\/JCP.08m04152","article-title":"Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.","volume":"70","author":"van der Loos","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.","volume":"61","author":"Calabrese","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4088\/JCP.v63n1110","article-title":"Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.","volume":"63","author":"Calabrese","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine-associated rash: risk\/benefit considerations in adults and children.","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"issue":"4","key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00130832-200108000-00007","article-title":"Reactive metabolites and their role in drug reactions.","volume":"1","author":"Naisbitt","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"27","key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.2174\/138161208786369713","article-title":"Hypersensitivity to lamotrigine and nonaromatic anticonvulsant drugs: a review.","volume":"14","author":"Gaeta","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"11","key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/tx0000825","article-title":"Metabolism of lamotrigine to a reactive arene oxide intermediate.","volume":"13","author":"Maggs","year":"2000","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"R18-9-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0920-1211(02)00033-5","article-title":"Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin.","volume":"49","author":"Anderson","year":"2002","journal-title":"Epilepsy Res"},{"issue":"7","key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1124\/dmd.107.015271","article-title":"Possible bioactivation pathways of lamotrigine.","volume":"35","author":"Lu","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"suppl 5","key":"R20-9-20210203","first-page":"S164","article-title":"Skin rash associated with Lamictal: incidence, time to onset and risk factors.","volume":"37","author":"Manasco","year":"1996","journal-title":"Epilepsia"},{"issue":"3","key":"R22-9-20210203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0920-1211(96)01007-8","article-title":"Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group.","volume":"26","author":"Brodie","year":"1997","journal-title":"Epilepsy Res"},{"issue":"3","key":"R23-9-20210203","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00002018-200427030-00002","article-title":"Safety and tolerability of lamotrigine for bipolar disorder.","volume":"27","author":"Bowden","year":"2004","journal-title":"Drug Saf"},{"issue":"4","key":"R24-9-20210203","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.55.4.588","article-title":"Adding valproate to lamotrigine: a study of their pharmacokinetic interaction.","volume":"55","author":"Kanner","year":"2000","journal-title":"Neurology"},{"issue":"9","key":"R25-9-20210203","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneur.62.9.1432","article-title":"Effect of antiepileptic drug comedication on lamotrigine clearance.","volume":"62","author":"Weintraub","year":"2005","journal-title":"Arch Neurol"},{"issue":"4","key":"R27-9-20210203","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1399-5618.2004.00106.x","article-title":"Successful rechallenge with slowly titrated lamotrigine after rash.","volume":"6","author":"Manfredi","year":"2004","journal-title":"Bipolar Disord"},{"issue":"2","key":"R28-9-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4088\/JCP.v59n0207h","article-title":"Recurrence of lamotrigine-associated rash with rechallenge.","volume":"59","author":"Buzan","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"R29-9-20210203","first-page":"27","article-title":"Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature.","volume":"7","author":"Aiken","year":"2010","journal-title":"Psychiatry (Edgmont)"},{"issue":"3","key":"R30-9-20210203","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-0404.2005.00381.x","article-title":"Lamotrigine-induced rash-worth a rechallenge.","volume":"111","author":"Codrea Tigaran","year":"2005","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"R31-9-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1059-1311(05)80082-2","article-title":"Rechallenge with lamotrigine after initial rash.","volume":"4","author":"Tavernor","year":"1995","journal-title":"Seizure"},{"issue":"11","key":"R32-9-20210203","first-page":"566","article-title":"Lamotrigine-related skin rashes in adults.","volume":"18","author":"Huang","year":"2002","journal-title":"Kaohsiung J Med Sci"},{"issue":"4","key":"R33-9-20210203","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/seiz.2000.0394","article-title":"Successful re-introduction of lamotrigine after initial rash.","volume":"9","author":"Besag","year":"2000","journal-title":"Seizure"},{"issue":"11","key":"R34-9-20210203","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00023210-200317110-00002","article-title":"Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy.","volume":"17","author":"Biton","year":"2003","journal-title":"CNS Drugs"},{"issue":"3","key":"R35-9-20210203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12325-009-0011-z","article-title":"Teratogenesis associated with antibipolar agents.","volume":"26","author":"Nguyen","year":"2009","journal-title":"Adv Ther"},{"issue":"suppl 9","key":"R36-9-20210203","first-page":"29","article-title":"Teratogenicity and anticonvulsants: lessons from neurology to psychiatry.","volume":"68","author":"Viguera","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R37-9-20210203","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"R38-9-20210203","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1017\/S0317167100034910","article-title":"Rash in adult and pediatric patients treated with lamotrigine.","volume":"25","author":"Messenheimer","year":"1998","journal-title":"Can J Neurol Sci"},{"issue":"8","key":"R39-9-20210203","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1212\/WNL.53.8.1724","article-title":"A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.","volume":"53","author":"Duchowny","year":"1999","journal-title":"Neurology"},{"issue":"25","key":"R40-9-20210203","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"R41-9-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0920-1211(01)00250-9","article-title":"Normal growth during lamotrigine monotherapy in pediatric epilepsy patients - a prospective evaluation of 103 children and adolescents.","volume":"46","author":"Ueberall","year":"2001","journal-title":"Epilepsy Res"},{"issue":"1","key":"R42-9-20210203","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/cap.2008.0107","article-title":"Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder.","volume":"19","author":"Pavuluri","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"10","key":"R44-9-20210203","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/gps.1784","article-title":"Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia.","volume":"22","author":"Sajatovic","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"issue":"8","key":"R45-9-20210203","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2165\/00002512-200118080-00006","article-title":"The tolerability of lamotrigine in elderly patients with epilepsy.","volume":"18","author":"Giorgi","year":"2001","journal-title":"Drugs Aging"},{"issue":"8","key":"R46-9-20210203","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/070674370204700808","article-title":"Lamotrigine use in geriatric patients with bipolar depression.","volume":"47","author":"Robillard","year":"2002","journal-title":"Can J Psychiatry"},{"issue":"4","key":"R47-9-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00019442-200504000-00006","article-title":"Maintenance treatment outcomes in older patients with bipolar I disorder.","volume":"13","author":"Sajatovic","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"R48-9-20210203","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/clpt.1987.193","article-title":"Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans.","volume":"42","author":"Cohen","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"R49-9-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-9236(96)90130-7","article-title":"Bidirectional interaction of valproate and lamotrigine in healthy subjects.","volume":"60","author":"Anderson","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"R50-9-20210203","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1528-1157.2000.tb00218.x","article-title":"Methsuximide lowers lamotrigine blood levels: a pharmacokinetic antiepileptic drug interaction.","volume":"41","author":"Besag","year":"2000","journal-title":"Epilepsia"},{"issue":"4","key":"R51-9-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002280000146","article-title":"Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects.","volume":"56","author":"Ebert","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"R52-9-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00007691-199904000-00007","article-title":"Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.","volume":"21","author":"May","year":"1999","journal-title":"Ther Drug Monit"},{"issue":"4","key":"R53-9-20210203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00003088-199631040-00006","article-title":"Pharmacokinetic interactions of the new antiepileptic drugs.","volume":"31","author":"Rambeck","year":"1996","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"R54-9-20210203","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","article-title":"Oral contraceptives reduce lamotrigine plasma levels.","volume":"61","author":"Sabers","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"R56-9-20210203","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1059-1311(98)80074-5","article-title":"Lamotrigine toxicity secondary to sertraline.","volume":"7","author":"Kaufman","year":"1998","journal-title":"Seizure"},{"issue":"11","key":"R57-9-20210203","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1176\/appi.ajp.158.11.1930","article-title":"Elevated clozapine plasma level with lamotrigine.","volume":"158","author":"Kossen","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"3","key":"R58-9-20210203","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0920-1211(97)00053-3","article-title":"Effect of lamotrigine on carbamazepine epoxide\/carbamazepine serum concentration ratios in adult patients with epilepsy.","volume":"28","author":"Gidal","year":"1997","journal-title":"Epilepsy Res"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201101000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:47:17Z","timestamp":1786042037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201101000-00009"}},"subtitle":["Results From 12 Placebo-Controlled Clinical Trials and Clinical Implications"],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3182055c07","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}